Clinical Trials

Lundbeck’s mission is to improve the quality of life of people suffering from psychiatric and neurological disorders and we are grateful to the patients, healthy volunteers, families, and clinics that participate in our clinical trials. Each individual’s participation contributes to our understanding of disease and has the potential to benefit patients around the world.

Lundbeck registers clinical trial protocols and discloses the results of clinical trials, regardless of outcome, in a publicly accessible clinical trial registry ( In addition, clinical trial protocols and results information submitted by Lundbeck to the EudraCT database is made publicly available by the European Medicines Agency (EMA) via its clinical trial registry: Clinical trial reports will be accessible on the EudraCT site in accordance with EMA POLICY/0070. Non-interventional studies may also be disclosed if, for example, they are considered to provide important safety data. 

Lundbeck will seek to ensure that disclosure of clinical trial information follows the IFPMA, EFPIA, JPMA, and PhRMA joint position paper “Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases”, the Declaration of Helsinki, and other relevant clinical trial disclosure requirements.

Cookie Policy
You have chosen to leave Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on